Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
NCT00899769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-03-14
Summary
RATIONALE: Studying samples of blood, tissue, and saliva in the laboratory from patients with cancer and from healthy volunteers may help doctors identify and learn more about biomarkers related to cancer.
PURPOSE: This laboratory study is looking at biomarkers in patients with head and neck cancer and in healthy volunteers.
Conditions
Interventions
- GENETIC
-
protein expression analysis
- GENETIC
-
proteomic profiling
- OTHER
-
immunoenzyme technique
- OTHER
-
laboratory biomarker analysis
- OTHER
-
liquid chromatography
- OTHER
-
mass spectrometry
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Wendell G. Yarbrough, MD, FACS · Vanderbilt-Ingram Cancer Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-04-30
Countries
- United States
Study Locations
More Related Trials
-
Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
NCT00896675 ·Status: COMPLETED
-
Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer
NCT00897052 ·Status: COMPLETED
-
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
NCT00580203 ·Status: COMPLETED
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
NCT00568490 ·Status: RECRUITING
-
Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
NCT00898300 ·Status: COMPLETED
-
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
NCT01487733 ·Status: COMPLETED
-
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
NCT01187173 ·Status: COMPLETED
-
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
NCT06420219 ·Status: RECRUITING
-
Biomarkers in Patients With Head and Neck Cancer
NCT01466257 ·Status: COMPLETED
-
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00898742 ·Status: TERMINATED
-
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT04099290 ·Status: RECRUITING
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Biomarker Analysis of Central Nervous System Tumors
NCT02692898 ·Status: TERMINATED
-
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
NCT05122507 ·Status: UNKNOWN
-
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
NCT00482872 ·Status: COMPLETED
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
NCT00349830 ·Status: RECRUITING
-
Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00898911 ·Status: COMPLETED
-
Biospecimen Procurement for Head and Neck Disorders
NCT03429036 ·Status: RECRUITING
-
Liquid Biopsy in Head and Neck Cancer
NCT03926468 ·Status: UNKNOWN
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
NCT00900276 ·Status: COMPLETED
-
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
NCT01150682 ·Status: UNKNOWN
-
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
NCT01344837 ·Status: COMPLETED